Table 2.
Toxicity | Grade | Control group | Study group | χ2 value |
Leukopenia | I | 6 | 10 | |
II | 2 | 8 | 3.41 | |
III | 0 | 3 | ||
IV | 0 | 0 | ||
GI tract | I | 8 | 3 | |
II | 5 | 10 | ||
III | 5 | 6 | 0.66 | |
IV | 1 | 2 | ||
Proctitis | I | 10 | 9 | |
II | 6 | 8 | ||
III | 3 | 3 | 0.01 | |
IV | 0 | 0 | ||
Skin | I | 5 | 3 | |
II | 8 | 9 | ||
III | 12 | 11 | 0.00 | |
IV | 0 | 0 | ||
Peripheral neuropathy | I | 0 | 10 | |
II | 0 | 4 | 1.09 | |
III | 0 | 1 | ||
Bladder | I | 12 | 11 | |
II | 6 | 8 | ||
III | 2 | 1 | 0.27 | |
IV | 0 | 0 |
P > 0.05. P value was calculated by subgroups for toxicity grade ≥ 3.